TEVAOXALI 5 MG/ML SOL INJ CT FA VD TRANS X 40 ML
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1557300050063 -
GGREM
537501005154413 -
Código de barras
7898919603084
O que a fonte publica
- Detentor do registro
- TEVA FARMACÊUTICA LTDA.
- Princípios ativos
- OXALIPLATINA
- Embalagem
- 5 MG/ML SOL INJ CT FA VD TRANS X 40 ML
- Tipo de produto
- Similar
- Classe terapêutica
- L1F - COMPOSTOS ANTINEOPLÁSICOS DE PLATINA
Nomes pelos quais este registro é encontrado
Dados completos da fonte
{
"name": "TEVAOXALI 5 MG/ML SOL INJ CT FA VD TRANS X 40 ML",
"holder": "TEVA FARMACÊUTICA LTDA.",
"stripe": null,
"barcodes": [
"7898919603084"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "537501005154413",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "05.333.542/0001-08",
"priceRegime": "Regulado",
"productName": "TEVAOXALI",
"productType": "Similar",
"hospitalOnly": true,
"presentation": "5 MG/ML SOL INJ CT FA VD TRANS X 40 ML",
"sourceStatus": null,
"supplyRegime": null,
"factoryPrices": {
"icms-0": "11067.89",
"icms-12": "12577.15",
"icms-17": "13334.80",
"icms-18": "13497.42",
"icms-19": "13664.06",
"icms-20": "13834.86",
"icms-21": "14009.99",
"icms-22": "14189.60",
"icms-23": "14373.88",
"icms-17.5": "13415.62",
"icms-19.5": "13748.93",
"icms-20.5": "13921.88",
"icms-22.5": "14281.15",
"icms-12-alc": "12426.22",
"icms-17-alc": "13174.78",
"icms-18-alc": "13335.46",
"icms-19-alc": "13500.09",
"icms-20-alc": "13668.83",
"icms-21-alc": "13841.87",
"icms-22-alc": "14019.32",
"icms-23-alc": "14201.39",
"withoutTaxes": "10935.08",
"icms-17.5-alc": "13254.63",
"icms-19.5-alc": "13583.94",
"icms-20.5-alc": "13754.81",
"icms-22.5-alc": "14109.78"
},
"pisCofinsList": "Positiva",
"substanceText": "OXALIPLATINA",
"targetSpecies": [],
"consumerPrices": null,
"invalidBarcodes": [],
"activeSubstances": [
"OXALIPLATINA"
],
"therapeuticClass": "L1F - COMPOSTOS ANTINEOPLÁSICOS DE PLATINA",
"commercialisation": {
"year": 2025,
"marketed": true
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1557300050063",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "unknown",
"prescriptionRequired": null,
"therapeuticClassCode": "L1F",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:537501005154413"